Amplifon Stock Price, News & Analysis
Company Description
Amplifon (OTC Link: AMFPY) is a publicly traded medical distribution company in the Healthcare sector. The company has a market capitalization of $5.0B.
AMFPY stock has declined 47.8% over the past year. Shares last traded at $46.99.
This page provides a comprehensive overview of AMFPY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Amplifon (AMFPY) stock last traded at $46.99. Over the past 12 months, the stock has lost 47.8%. At a market capitalization of $5.0B, AMFPY is classified as a mid-cap stock with approximately 55.0M shares outstanding.
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Amplifon (AMFPY) currently stands at 82 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 83.6%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Amplifon (AMFPY) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 16511.1% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
AMFPY Company Profile & Sector Positioning
Amplifon (AMFPY) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing AMFPY often look at related companies in the same sector, including Carl Zeiss Medit (CZMWY), Getinge (GNGBY), Ambu A/S (AMBBY), Convatec Group (CNVVY), and Ansell (ANSLY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AMFPY's relative position within its industry.